-
Recombinant Human SARS-CoV-2 Spike Glycoprotein S1 RBD (HEK)715.H16.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human SARS-CoV-2 Nucleoprotein (HEK)715.H17.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human Angiotensin-converting enzyme 2 (ACE2) Extracellular Domain 19-615 (HEK)715.H19.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human SARS-CoV-2 Spike RBD, Variant 501Y.V1, Lineage B.1.1.7, UK (HEK)715.H20.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human SARS-CoV-2 Spike RBD, Variant 501Y.V2, Lineage B.1.351, South Africa (HEK)715.H21.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human SARS-CoV-2 Spike RBD, Variant 501Y.V3 Lineage B.1.1.248, Brazil & Japan (HEK)715.H22.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human SARS-CoV-2 Spike RBD, Variant Lineage B.1.617, India (HEK)715.H24.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-
-
Recombinant Human SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2 (HEK)715.H25.0BU-
Recombinant Protein
-
Antigens > Infectious Diseases > SARS-CoV-2
-